Breakthrough T1D and Gore Invest in Development of Implantable Insulin Delivery System
PhysioLogic Devices, a Breakthrough T1D-funded company that is dedicated to transforming the treatment of type 1 diabetes (T1D), wants to…
FDA Grants Breakthrough Device Status: iLet Bionic Pancreas
Earlier this week, Beta Bionics announced that the Food and Drug Administration (FDA) has granted breakthrough device designation to the…
FDA Authorizes a Second Artificial Pancreas System
The Food and Drug Administration (FDA) today authorized an algorithm that enables the second artificial pancreas system: The Control-IQ™ advanced…
This Stent is a Champion for Type 1 Diabetes Clinical Trials
Maribeth Stent was diagnosed with type 1 diabetes (T1D) in the fall of 1997. “It was right around my second…
Two T1D Technology Leaders Partnering to Drive Innovation and Choice
Two leading innovators in the type 1 diabetes (T1D) space have announced a collaborative partnership aimed at enabling those with…
A New AP System by Tandem Shows Key Time-in-Range Benefits
A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with…
ADA Scientific Sessions Recap—Day #3: Dan Finan, Ph.D.
There was some really amazing results out here in San Francisco! Here is Dan Finan, Ph.D., head of the Breakthrough…
A DIY Approach to Artificial Pancreas Technology
What do Aaron Kowalski, Ph.D., president and CEO of Breakthrough T1D, and Jeremy Pettus, M.D., an endocrinologist at the University…
Insulin Discovered Nearly 100 Years Ago: How Far We’ve Come and the Road Ahead
Incredible strides have been made since the discovery of insulin almost 100 years ago. Insulin formulations have improved dramatically, blood-sugar…
In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control
Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps using algorithms to manage insulin. Learn…
